ZA200200619B - Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof. - Google Patents

Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof.

Info

Publication number
ZA200200619B
ZA200200619B ZA200200619A ZA200200619A ZA200200619B ZA 200200619 B ZA200200619 B ZA 200200619B ZA 200200619 A ZA200200619 A ZA 200200619A ZA 200200619 A ZA200200619 A ZA 200200619A ZA 200200619 B ZA200200619 B ZA 200200619B
Authority
ZA
South Africa
Prior art keywords
cyclobenzaprine
compositions
anxiety disorder
generalized anxiety
treating generalized
Prior art date
Application number
ZA200200619A
Other languages
English (en)
Inventor
Seth Lederman
Iredell W Iglehart Iii
Original Assignee
Vela Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vela Pharmaceuticals Inc filed Critical Vela Pharmaceuticals Inc
Publication of ZA200200619B publication Critical patent/ZA200200619B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
ZA200200619A 1999-08-13 2002-01-23 Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof. ZA200200619B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14888199P 1999-08-13 1999-08-13

Publications (1)

Publication Number Publication Date
ZA200200619B true ZA200200619B (en) 2003-04-23

Family

ID=22527835

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200200619A ZA200200619B (en) 1999-08-13 2002-01-23 Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof.
ZA200200852A ZA200200852B (en) 1999-08-13 2002-01-30 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200200852A ZA200200852B (en) 1999-08-13 2002-01-30 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine.

Country Status (18)

Country Link
US (3) US6395788B1 (es)
EP (1) EP1202722B1 (es)
JP (1) JP2003506484A (es)
AR (1) AR025110A1 (es)
AT (1) ATE299369T1 (es)
AU (1) AU6635400A (es)
BR (1) BR0013017A (es)
CA (1) CA2380432A1 (es)
DE (1) DE60021266T2 (es)
ES (2) ES2192156B1 (es)
GB (1) GB2368522A (es)
HK (2) HK1047883A1 (es)
IL (1) IL147777A0 (es)
MX (1) MXPA02001569A (es)
NZ (1) NZ516749A (es)
PT (1) PT1202722E (es)
WO (1) WO2001012175A1 (es)
ZA (2) ZA200200619B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002537245A (ja) * 1999-02-18 2002-11-05 ノバルティス アクチエンゲゼルシャフト ５−ｈｔ３レセプターアンタゴニストの使用
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
JP4578083B2 (ja) * 2003-09-30 2010-11-10 小林製薬株式会社 催眠剤組成物
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
EP1954669B1 (en) 2005-12-01 2015-07-08 Auspex Pharmaceuticals, Inc. Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
CA2641821C (en) * 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US20100179215A1 (en) * 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
PL2125698T3 (pl) * 2007-03-15 2017-03-31 Auspex Pharmaceuticals, Inc. Deuterowana wenlafaksyna-d9
BRPI0818654A2 (pt) 2007-10-09 2015-04-07 Imthera Medical Inc Aparelho, sistema e método para estimulação seletiva
US8629135B2 (en) * 2008-07-14 2014-01-14 Queen's University At Kingston Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer
US8428725B2 (en) 2008-10-09 2013-04-23 Imthera Medical, Inc. Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue
US9498440B2 (en) 2009-05-22 2016-11-22 Inventia Healthcare Private Limited Extended release pharmaceutical compositions
AU2010318651A1 (en) * 2009-11-10 2012-05-03 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
EP2501234B1 (en) 2009-11-20 2017-09-13 Tonix Pharma Holdings Limited Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
US20110319389A1 (en) * 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US20120232159A1 (en) * 2011-03-07 2012-09-13 Tonix Pharmaceuticals, Inc. Methods and Compositions for Treating Depression using Cyclobenzaprine
ITMI20110558A1 (it) * 2011-04-06 2012-10-07 Campiglio Consulting Srl Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale
WO2013168004A2 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of fibromyalgia pain
CA3118913C (en) 2012-06-15 2024-04-30 Tonix Pharma Holdings Limited Compositions and methods for transmucosal absorption
US10117936B2 (en) 2013-03-15 2018-11-06 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
CA2961822A1 (en) 2014-09-18 2016-03-24 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride
JP2020526592A (ja) 2017-07-13 2020-08-31 トニックス ファーマシューティカルズ ホールディング コーポレーション シクロベンザプリン類似体及びアミトリプチレン類似体
CA3083341A1 (en) 2017-12-11 2019-06-20 Tonix Pharma Holdings Limited Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
AU2019323764A1 (en) * 2018-08-20 2021-03-11 Tonix Pharma Holdings Limited Methods of treating acute stress disorder and posttraumatic stress disorder
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
AU2021253592A1 (en) * 2020-04-08 2022-11-10 Tonix Pharmaceuticals Holding Corp. Cyclobenzaprine treatment for sexual dysfunction
JP2023554597A (ja) 2020-11-20 2023-12-28 トニックス ファーマシューティカルズ ホールディング コーポレイション アルコール使用障害のためのシクロベンザプリン処置
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1339636A (en) * 1917-02-23 1920-05-11 Tulloch Thomas Gregorie Fluid-tight joint for steam-pipes and the like
GB859187A (en) 1958-11-25 1961-01-18 United States Borax Chem Method for preparing substituted tris amino boranes
CA958643A (en) 1970-07-07 1974-12-03 Frosst (Charles E.) And Co. Pharmaceutical compositions containing cyclobenzaprine
FR2121529A1 (en) * 1971-01-05 1972-08-25 Merck & Co Inc Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid
MXPA02001568A (es) * 1999-08-13 2002-07-02 Vela Pharmaceuticals Inc Ciclobenzaprina para tratar trastornos de ansiedad generalizada y composiciones de la misma.

Also Published As

Publication number Publication date
WO2001012175A8 (en) 2001-05-10
GB0202908D0 (en) 2002-03-27
BR0013017A (pt) 2002-04-16
WO2001012175A1 (en) 2001-02-22
US20010046988A1 (en) 2001-11-29
ES2192156A1 (es) 2003-09-16
ES2245944T3 (es) 2006-02-01
ZA200200852B (en) 2003-07-30
US20040029869A1 (en) 2004-02-12
AR025110A1 (es) 2002-11-06
HK1047883A1 (zh) 2003-03-14
US6541523B2 (en) 2003-04-01
DE60021266D1 (de) 2005-08-18
HK1047691B (zh) 2006-05-12
GB2368522A8 (en) 2002-06-13
IL147777A0 (en) 2002-08-14
CA2380432A1 (en) 2001-02-22
EP1202722B1 (en) 2005-07-13
US6395788B1 (en) 2002-05-28
ATE299369T1 (de) 2005-07-15
PT1202722E (pt) 2005-11-30
AU6635400A (en) 2001-03-13
MXPA02001569A (es) 2002-07-02
HK1047691A1 (en) 2003-03-07
EP1202722A1 (en) 2002-05-08
NZ516749A (en) 2004-03-26
ES2192156B1 (es) 2005-02-16
JP2003506484A (ja) 2003-02-18
DE60021266T2 (de) 2006-05-24
GB2368522A (en) 2002-05-08

Similar Documents

Publication Publication Date Title
ZA200200619B (en) Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof.
HK1047692A1 (zh) 治療全身性焦慮障礙的環苯扎林及其組合物
EP1200086A4 (en) THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
DE60136818D1 (en) 17.beta.-carbothioat 17.alpha.-arylkarbonyloxyloxy androstanderivate als anti-phlogistische medikamente
EP1128832A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
MXPA03004401A (es) Metodos y dispositivos para tratar problemas de tartamudez.
EG23292A (en) Textile finishing composition and methods for using same.
IL144561A0 (en) Liposome compositions and methods for treating pests utilizing the same
MX246293B (es) Composiciones y metodos para tratar hiperpigmentacion.
DK1071433T3 (da) 2',2'-difluornucleosider til immunosuppressiv behandling og kombinationspræparater
ZA995806B (en) Integrated direct reduction iron system.
HK1041827A1 (en) Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame.
HUP0303261A3 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
MXPA01011923A (es) Composiciones y metodos para tratar alteraciones en la proliferacion celular.
HK1042847A1 (zh) 骨代謝異常症治療劑
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
ZA200203435B (en) Method and compositions for treating pulmonary diseases.
ZA200206252B (en) Method and compositions for treating an inflammatory disease.
IL145220A0 (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
ZA200003926B (en) Topiramate and related derivatives for treating Schizophrenia.
ZA200101188B (en) DNAzymes and methods for treating restenosis.
IL149314A0 (en) Agent for treating hepatitis c
ZA200204018B (en) Combination treatment for depression and anxiety.